Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Relapsing C. difficile disease in humans is linked to a pathological imbalance within the intestinal microbiota, termed dysbiosis, which remains poorly understood. We show that mice infected with epidemic C. difficile (genotype 027/BI) develop highly contagious, chronic intestinal disease and persistent dysbiosis characterized by a distinct, simplified microbiota containing opportunistic pathogens and altered metabolite production. Chronic C. difficile 027/BI infection was refractory to vancomycin treatment leading to relapsing disease. In contrast, treatment of C. difficile 027/BI infected mice with feces from healthy mice rapidly restored a diverse, healthy microbiota and resolved C. difficile disease and contagiousness. We used this model to identify a simple mixture of six phylogenetically diverse intestinal bacteria, including novel species, which can re-establish a health-associated microbiota and clear C. difficile 027/BI infection from mice. Thus, targeting a dysbiotic microbiota with a defined mixture of phylogenetically diverse bacteria can trigger major shifts in the microbial community structure that displaces C. difficile and, as a result, resolves disease and contagiousness. Further, we demonstrate a rational approach to harness the therapeutic potential of health-associated microbial communities to treat C. difficile disease and potentially other forms of intestinal dysbiosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Whole genome (maximum likelihood) phylogeny of intestinal bacteria demonstrating the phylogenetic placement of disease-resolving bacteriotherapy bacteria (MixB) and the dominant members of the supershedder microbiota. Maximum likelihood phylogeny produced using FastTree from the concatenated protein sequence of 44 common genes (See methods). Species names marked in green indicate members of the suppressive MixB mixture, names marked in red indicate species that were commonly detected in the feces of supershedding mice, names in black are reference genomes from common intestinal bacteria that were included to provide phylogenetic context to the tree. Taxonomic designations are given at the relevant branch nodes. Adjacent pictures are transmission electron micrographs of sectioned bacterial strains that constitute MixB. Methods for sample processing and imaging have been described [33]. Scale bars are shown below bacteria.](https://figures.cochat.ai/paper-figures/d26cd52a622e48fbb6e5369ce372b754/targeted-restoration-of-the-intestinal-microbiota-with-a-simple-defined-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Decrease in Lachnospiraceae has been associated with severe CDI suggesting a protective role for members of this family51”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“Bacterial strains [54, 118, 119] and metabolites [54] associated with protection from C. difficile have now been identified”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,491
ARB: a software environment for sequence data
Ludwig, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh293 · Cited by 6,702
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation
Letunic, I., & Bork, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btl529 · Cited by 3,299
Identifying bacterial genes and endosymbiont DNA with Glimmer
Delcher, A. L., Bratke, K. A., Powers, E. C., & Salzberg, S. L. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm009 · Cited by 3,134
Colonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715 · cited 1×
“Adjusted p-values were calculated using the Benjamini and Hochberg method [57].”
MethodSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501
Cited by
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
“Bacterial strains [54,118,119] and metabolites [54] associated with protection from C.”
BackgroundClostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
The chicken gastrointestinal microbiome
Oakley, B. B., Lillehoj, H. S., Kogut, M. H., Kim, W. K., Maurer, J. J., Pedroso, A., Lee, M. D., Collett, S. R., Johnson, T. J., & Cox, N. A. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12608 · Cited by 799
“difficile infections in humans (Anderson et al., 2012; Lawley et al., 2012; Van Nood et al., 2013), although the underlying mechanisms remain poorly understood in all cases.”
BackgroundMechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Fröhlich, E. E., Farzi, A., Mayerhofer, R., Reichmann, F., Jačan, A., Wagner, B., Zinser, E., Bordag, N., Magnes, C., Fröhlich, E., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.020 · Cited by 720
“Group B was habituated to the Barnes maze (BM) on day 7.”
MethodGoodrich, J. K., Di Rienzi, S. C., Poole, A. C., Koren, O., Walters, W. A., Caporaso, J. G., Knight, R., & Ley, R. E. (2014) · Cell · doi:10.1016/j.cell.2014.06.037 · Cited by 714
“Separately maintained mice can then be cohoused to demonstrate the spread of a microbiota between adults (Lawley et al., 2012; Ridaura et al., 2013).”
BackgroundFate, activity, and impact of ingested bacteria within the human gut microbiota
Derrien, M., & van Hylckama Vlieg, J. E. T. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.03.002 · Cited by 605
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
Understanding the mechanisms of faecal microbiota transplantation
Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 561
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
“difficile shedding levels up to 6 weeks postinfection (121).”
BackgroundClostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
Citrobacter rodentium: infection, inflammation and the microbiota
Collins, J. W., Keeney, K. M., Crepin, V. F., Rathinam, V. A. K., Fitzgerald, K. A., Finlay, B. B., & Frankel, G. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3315 · Cited by 520
Antharam, V. C., Li, E. C., Ishmael, A., Sharma, A., Mai, V., Rand, K. H., & Wang, G. P. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-13 · Cited by 485
“difficile strain 027/BI in mice was associated with an altered SCFA profile characterized by marked reductions in butyrate and acetate levels (20).”
BackgroundResultTheriot, C. M., Bowman, A. A., & Young, V. B. (2016) · mSphere · doi:10.1128/msphere.00045-15 · Cited by 481
Sorbara, M. T., & Pamer, E. G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00667-9 · Cited by 468
Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu135 · Cited by 467
“Fecal microbiota transplantation (FMT) reconstitution of normal flora by a stool transplant from a healthy individual - has been a successful therapeutic approach to recurrent/refractory CDI in animal studies [14], numerous case series [15–20] and, more recently, a single randomized clinical trial [21].”
BackgroundRole of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile
Britton, R. A., & Young, V. B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.059 · Cited by 446
“In addition, each community shares few organisms at the genus level, indicating there will be many combinations that can suppress CDI.”
BackgroundInfluentialThe native microbiome of the nematode Caenorhabditis elegans: gateway to a new host-microbiome model
Dirksen, P., Marsh, S. A., Braker, I., Heitland, N., Wagner, S., Nakad, R., Mader, S., Petersen, C., Kowallik, V., Rosenstiel, P., et al. (2016) · BMC Biology · doi:10.1186/s12915-016-0258-1 · Cited by 439
“Conversely, a distorted microbiome can be cause of many diseases, for example, antibiotic-associated diarrhea caused by Clostridium difficile [12], obesity [13], or liver cirrhosis [14].”
BackgroundResurrecting the intestinal microbiota to combat antibiotic-resistant pathogens
Pamer, E. G. (2016) · Science · doi:10.1126/science.aad9382 · Cited by 418
Smillie, C. S., Sauk, J., Gevers, D., Friedman, J., Sung, J., Youngster, I., Hohmann, E. L., Staley, C., Khoruts, A., Sadowsky, M. J., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.003 · Cited by 411
“Consistent with this hypothesis, a mixture of six bacterial strains can treat recurrent C. difficile infection in mice (Lawley et al., 2012).”
BackgroundAn exclusive metabolic niche enables strain engraftment in the gut microbiota
Shepherd, E. S., DeLoache, W. C., Pruss, K. M., Whitaker, W. R., & Sonnenburg, J. L. (2018) · Nature · doi:10.1038/s41586-018-0092-4 · Cited by 367
Hooks, K. B., & O’Malley, M. A. (2017) · mBio · doi:10.1128/mbio.01492-17 · Cited by 382
Ferreyra, J. A., Wu, K. J., Hryckowian, A. J., Bouley, D. M., Weimer, B. C., & Sonnenburg, J. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.003 · Cited by 378
“The successful use of six bacterial species to cure persistent infection in mice, but failure of other cocktails of six or fewer species underscores the current poor understanding of ecological relationships that underlie C. difficile disease (Lawley et al. 2012).”
BackgroundHeterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design
Laukens, D., Brinkman, B. M., Raes, J., De Vos, M., & Vandenabeele, P. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv036 · Cited by 379
“difficile could be cured with feces from healthy mice (Lawley et al. 2012), in accordance with the successful treatment of human relapsing C.”
ResultPop, M., Walker, A. W., Paulson, J., Lindsay, B., Antonio, M., Hossain, M. A., Oundo, J., Tamboura, B., Mai, V., Astrovskaya, I., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-6-r76 · Cited by 376
“For example, microbiological [39] or dietary [26] interventions may be possible in the supportive treatment of diarrhea in children similar to approaches used in the management of enteric infections in adults [39-41].”
ResultMicrobial nutrient niches in the gut
Pereira, F. C., & Berry, D. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13659 · Cited by 369
“In some cases, more than one strain is needed to saturate potential nutrient niches available to incoming strains and thereby block colonization (Lawley et al., 2012; Stecher et al., 2013; Brugiroux et al., 2016).”
BackgroundCooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium
Caballero, S., Kim, S., Carter, R. A., Leiner, I. M., Sušac, B., Miller, L., Kim, G. J., Ling, L., & Pamer, E. G. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.002 · Cited by 308
“The identification of bacterial strains that provide colonization resistance is challenging because they are, for the most part, obligate anaerobes, difficult to culture and sensitive to antibiotics that impair colonization resistance (Reeves et al., 2012; Lawley et al., 2012; Ubeda et al., 2013; Buffie et al., 2015).”
InfluentialHu, J., Ma, L., Nie, Y., Chen, J., Zheng, W., Wang, X., Xie, C., Zheng, Z., Wang, Z., Yang, T., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.11.006 · Cited by 334
“Therefore, precise manipulating intestinal microbiota via the use of probiotics has become a promising strategy for gastrointestinal disorders therapy (Buffie et al., 2015; Foxx-Orenstein and Chey, 2012; Lawley et al., 2012; Schieber et al., 2015).”
BackgroundRecovery of the Gut Microbiome following Fecal Microbiota Transplantation
Seekatz, A. M., Aas, J., Gessert, C. E., Rubin, T. A., Saman, D. M., Bakken, J. S., & Young, V. B. (2014) · mBio · doi:10.1128/mbio.00893-14 · Cited by 331
“difficile has been described for both human (14) and mouse (15, 16) studies following FMT therapy, but few studies have explored the functional changes following FMT.”
BackgroundFaecal microbiota transplantation protects against radiation‐induced toxicity
Cui, M., Xiao, H., Li, Y., Zhou, L., Zhao, S., Luo, D., Zheng, Q., Dong, J., Zhao, Y., Zhang, X., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606932 · Cited by 328
“For example, targeted restoration of the intestinal bacteria is beneficial in treating recalcitrant or recurring C. difficile infection (Lawley et al, 2012).”
BackgroundSorbara, M. T., & Pamer, E. G. (2019) · Mucosal Immunology · doi:10.1038/s41385-018-0053-0 · Cited by 320
Khanna, S., Pardi, D. S., Kelly, C. R., Kraft, C. S., Dhere, T., Henn, M. R., Lombardo, M.-J., Vulic, M., Ohsumi, T., Winkler, J., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv766 · Cited by 321
Schubert, A. M., Rogers, M. A. M., Ring, C., Mogle, J., Petrosino, J. P., Young, V. B., Aronoff, D. M., & Schloss, P. D. (2014) · mBio · doi:10.1128/mbio.01021-14 · Cited by 318
Pham, T. A. N., Clare, S., Goulding, D., Arasteh, J. M., Stares, M. D., Browne, H. P., Keane, J. A., Page, A. J., Kumasaka, N., Kane, L., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.017 · Cited by 305
“Therapeutic modulation of the microbiota, by dietary intake of prebiotic substances or administration of health-associated bacteria, therefore provides an attractive opportunity for the management of intestinal infections (Lawley et al., 2012).”
BackgroundInteractions Between the Gastrointestinal Microbiome and Clostridium difficile
Theriot, C. M., & Young, V. B. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104115 · Cited by 302
“difficile with a bacterial consortium made up of Staphylococcus, Enterococcus, Lactobacillus, Anaerostipes, Bacteroidetes, and Enterorhabdus (68).”
BackgroundSocial behavior shapes the chimpanzee pan-microbiome
Moeller, A. H., Foerster, S., Wilson, M. L., Pusey, A. E., Hahn, B. H., & Ochman, H. (2016) · Science Advances · doi:10.1126/sciadv.1500997 · Cited by 296
Abt, M. C., Lewis, B. B., Caballero, S., Xiong, H., Carter, R. A., Sušac, B., Ling, L., Leiner, I., & Pamer, E. G. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.011 · Cited by 294
“While progress has been made in identifying specific commensal bacterial species that can preventC. difficile replica- C tion (Buffie et al., 2015; Lawley et al., 2012; Seekatz et al., 2014; Tvede et al., 2015), the role of the host’s natural defenses in limiting disease severity is not well…”
BackgroundQi, X., Zhang, Y., Zhang, Y., Luo, F., Song, K., Wang, G., & Ling, F. (2023) · Microbiome · doi:10.1186/s40168-023-01574-2 · Cited by 285
“Recent studies have demonstrated that gut microbes form an interactive ecological network to maintain host health, while the lack of a stable microbiota structure contributes to host disease [11, 12].”
BackgroundMicrobiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus
Kim, S. G., Becattini, S., Moody, T. U., Shliaha, P. V., Littmann, E. R., Seok, R., Gjonbalaj, M., Eaton, V., Fontana, E., Amoretti, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1501-z · Cited by 283
Probiotics in Medicine: A Long Debate
Stavropoulou, E., & Bezirtzoglou, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02192 · Cited by 282
“difficile colitis, as well as treatment of gastroenteritis in addition to oral rehydration therapy (49, 50) (Table 1).”
BackgroundThe Microbiota and Microbiome in Aging: Potential Implications in Health and Age‐Related Diseases
Zapata, H. J., & Quagliarello, V. J. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13310 · Cited by 279
“difficile colitis in mice and caused expansion of healthy commensals.(36) Data from the human trial and mouse model support the concept that manipulating the intestinal microbiota using adoptive bacteriotherapy is a plausible strategy to reconstitute the intestinal microbiota and prevent recurrent CDI in older adults.”
Schubert, A. M., Sinani, H., & Schloss, P. D. (2015) · mBio · doi:10.1128/mbio.00974-15 · Cited by 276
“A six-species cocktail, including isolates of Porphyromonadaceae, Lachnospiraceae, Lactobacillus, Coriobacteriaceae, Staphylococcus, and Enterococcus, successfully resolved CDI in mice (22).”
BackgroundFecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
Borody, T. J., Paramsothy, S., & Agrawal, G. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0337-1 · Cited by 275
Universality of human microbial dynamics
Bashan, A., Gibson, T. E., Friedman, J., Carey, V. J., Weiss, S. T., Hohmann, E. L., & Liu, Y.-Y. (2016) · Nature · doi:10.1038/nature18301 · Cited by 270
“It is also possible that the abundance profiles of rCDI subjects are drastically varying over time and hence do not represent the steady states of the underlying microbial ecosystem (though a murine infection model doesn’t seem to support this hypothesis 34 ).”
Mullish, B. H., McDonald, J. A. K., Pechlivanis, A., Allegretti, J. R., Kao, D., Barker, G. F., Kapila, D., Petrof, E. O., Joyce, S. A., Gahan, C. G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317842 · Cited by 268
Massively parallel screening of synthetic microbial communities
Kehe, J., Kulesa, A., Ortiz, A., Ackerman, C. M., Thakku, S. G., Sellers, D., Kuehn, S., Gore, J., Friedman, J., & Blainey, P. C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900102116 · Cited by 263
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 261
“difficile 027/BI displayed a reduction in the intestinal bacterial diversity (Lawley et al., 2012).”
BackgroundProblems with the concept of gut microbiota dysbiosis
Brüssow, H. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13479 · Cited by 250
“Mice are commonly used for this demonstration, where mixtures of commensals (Lawley et al., 2012) and even single commensal strains (Buffie et al.”
BackgroundAn overview of fecal microbiota transplantation: techniques, indications, and outcomes
Brandt, L. J., & Aroniadis, O. C. (2013) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.03.1329 · Cited by 258
Clostridium difficile and the microbiota
Seekatz, A. M., & Young, V. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72336 · Cited by 255
“Lawley et al. were able to identify a population of 6 different bacteria that were efficient at clearing CDI in mice (93).”
BackgroundMicrobiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model
Hryckowian, A. J., Van Treuren, W., Smits, S. A., Davis, N. M., Gardner, J. O., Bouley, D. M., & Sonnenburg, J. L. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0150-6 · Cited by 248
“The correlation between Parabacteroides and Cd burden is consistent with previous observations that Parabacteroides are elevated in Cd “supershedder” mice 22 .”
Microbiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
Emerging roles of the microbiome in cancer
Bultman, S. J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt392 · Cited by 239
“difficile and resolved the disease as well as homogenized feces (65).”
BackgroundGut microbiome composition and diversity are related to human personality traits
Johnson, K. V.-A. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2019.100069 · Cited by 240
Transmission of the gut microbiota: spreading of health
Browne, H. P., Neville, B. A., Forster, S. C., & Lawley, T. D. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.50 · Cited by 232
Interactions in the microbiome: communities of organisms and communities of genes
Boon, E., Meehan, C. J., Whidden, C., Wong, D. H.-J., Langille, M. G. I., & Beiko, R. G. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12035 · Cited by 230
“, 2012) and controlled experiments (McNulty et al., 2011; Lawley et al., 2012; Xie et al., 2012; Badri et al., 2013; Smith et al., 2013), with rapid genetic assessment techniques providing much of the evidence for taxonomic and functional diversity.”
BackgroundRapid evolution of microbe-mediated protection against pathogens in a worm host
King, K. C., Brockhurst, M. A., Vasieva, O., Paterson, S., Betts, A., Ford, S. A., Frost, C. L., Horsburgh, M. J., Haldenby, S., & Hurst, G. D. D. (2016) · The ISME Journal · doi:10.1038/ismej.2015.259 · Cited by 224
“E. faecalis and S. aureus frequently occur in animal and human microbiomes (Holden et al., 2004; Martin-Vivaldi et al., 2010; Lawley et al., 2012; Cruz et al., 2013; Kommineni et al., 2015) wherein they can be pathogenic or commensal.”
BackgroundAcetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2
Fachi, J. L., Sécca, C., Rodrigues, P. B., Mato, F. C. P. D., Di Luccia, B., Felipe, J. D. S., Pral, L. P., Rungue, M., Rocha, V. D. M., Sato, F. T., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190489 · Cited by 220
Structure, Function, and Biology of the Enterococcus faecalis Cytolysin
Van Tyne, D., Martin, M., & Gilmore, M. (2013) · Toxins · doi:10.3390/toxins5050895 · Cited by 219
“This provides an opportunity for drug resistant enterococci to invade the intestinal niche and proliferate uncontrollably [3,20].”
BackgroundCommensal bacteria mediated defenses against pathogens
Abt, M. C., & Pamer, E. G. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.003 · Cited by 212
Byrd, A. L., & Segre, J. A. (2016) · Science · doi:10.1126/science.aad6753 · Cited by 206
Goverse, G., Molenaar, R., Macia, L., Tan, J., Erkelens, M. N., Konijn, T., Knippenberg, M., Cook, E. C. L., Hanekamp, D., Veldhoen, M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600165 · Cited by 200
“Particular combinations of bacteria might be needed to successfully restore symbiosis (15, 51, 53).”
BackgroundSeekatz, A. M., Theriot, C. M., Rao, K., Chang, Y.-M., Freeman, A. E., Kao, J. Y., & Young, V. B. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.04.001 · Cited by 198
“difficile in a murine model, resulting in a shift in short chain fatty acids (SCFAs) (23).”
BackgroundStuder, N., Desharnais, L., Beutler, M., Brugiroux, S., Terrazos, M. A., Menin, L., Schürch, C. M., McCoy, K. D., Kuehne, S. A., Minton, N. P., et al. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00191 · Cited by 195
“The importance of other species has also been demonstrated by the finding that therapeutic intestinal microbial cocktails may not need to include 7-dehydroxylating species to be effective (Lawley et al., 2012).”
BackgroundFecal Transplants: What Is Being Transferred?
Bojanova, D. P., & Bordenstein, S. R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002503 · Cited by 190
“There are a few studies in mice and humans that validate the positive effects of cultured bacteria on CDI [10,11] and mucosal barrier function [12].”
BackgroundProbiotics and prebiotics and health in ageing populations
Duncan, S. H., & Flint, H. J. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.02.004 · Cited by 187
Dysbiosis in intestinal inflammation: Cause or consequence
Buttó, L. F., & Haller, D. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.010 · Cited by 188
From Stool Transplants to Next-Generation Microbiota Therapeutics
Petrof, E. O., & Khoruts, A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.004 · Cited by 186
“50 Furthermore, consortia of specific bacterial species that protect against CDI in mice and humans have little phylogenetic similarity to C difficile.(50) 51 Of course, phylogenetically dissimilar bacterial species may still compete for the same limiting nutrients.”
BackgroundProcedures for Fecal Microbiota Transplantation in Murine Microbiome Studies
Bokoliya, S. C., Dorsett, Y., Panier, H., & Zhou, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.711055 · Cited by 185
“Lawley’s research group reported that FMT from a healthy donor mouse into recipient mouse with CDI led to resolution of illness and infection (Lawley et al., 2012).”
BackgroundReview article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 180
Engineering the gut microbiota to treat hyperammonemia
Shen, T.-C. D., Albenberg, L., Bittinger, K., Chehoud, C., Chen, Y.-Y., Judge, C. A., Chau, L., Ni, J., Sheng, M., Lin, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79214 · Cited by 180
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
McKenney, P. T., & Pamer, E. G. (2015) · Cell · doi:10.1016/j.cell.2015.11.032 · Cited by 181
Roles of the intestinal microbiota in pathogen protection
Ubeda, C., Djukovic, A., & Isaac, S. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.2 · Cited by 181
Fuentes, S., van Nood, E., Tims, S., Heikamp-de Jong, I., ter Braak, C. J. F., Keller, J. J., Zoetendal, E. G., & de Vos, W. M. (2014) · The ISME Journal · doi:10.1038/ismej.2014.13 · Cited by 175
“In mice, Bacteroides was found to be one of the genera involved in the recovery of disease after bacteriotherapy using a mix of bacteria (Lawley et al., 2012).”
BackgroundEberl, C., Weiss, A. S., Jochum, L. M., Durai Raj, A. C., Ring, D., Hussain, S., Herp, S., Meng, C., Kleigrewe, K., Gigl, M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.004 · Cited by 170
Song, Y., Garg, S., Girotra, M., Maddox, C., von Rosenvinge, E. C., Dutta, A., Dutta, S., & Fricke, W. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081330 · Cited by 172
“difficile infection in the mouse model was shown to alter SCFA profiles [52].”
BackgroundSignaling in Host-Associated Microbial Communities
Fischbach, M. A., & Segre, J. A. (2016) · Cell · doi:10.1016/j.cell.2016.02.037 · Cited by 172
Brandt, L. J. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.450 · Cited by 171
Lappan, R., Imbrogno, K., Sikazwe, C., Anderson, D., Mok, D., Coates, H., Vijayasekaran, S., Bumbak, P., Blyth, C. C., Jamieson, S. E., et al. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1154-3 · Cited by 162
“Other studies have identified bacteria with a protective role that are not closely related to the pathogens they inhibit [28, 29].”
BackgroundAbd El-Hack, M. E., El-Saadony, M. T., Elbestawy, A. R., El-Shall, N. A., Saad, A. M., Salem, H. M., El-Tahan, A. M., Khafaga, A. F., Taha, A. E., AbuQamar, S. F., et al. (2022) · Poultry Science · doi:10.1016/j.psj.2021.101590 · Cited by 159
“Human GI diseases, such as recurrent Clostridium difficile infection, were successfully treated by microbiota transplantation (Lawley et al., 2012).”
BackgroundSynthetic Microbes As Drug Delivery Systems
Claesen, J., & Fischbach, M. A. (2015) · ACS Synthetic Biology · doi:10.1021/sb500258b · Cited by 158
Lung Microbiome for Clinicians. New Discoveries about Bugs in Healthy and Diseased Lungs
Segal, L. N., Rom, W. N., & Weiden, M. D. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201310-339fr · Cited by 169
Oakley, B. B., Buhr, R. J., Ritz, C. W., Kiepper, B. H., Berrang, M. E., Seal, B. S., & Cox, N. A. (2014) · BMC Veterinary Research · doi:10.1186/s12917-014-0282-8 · Cited by 181
“The importance of GI microbial communities for the health and nutrition of the host organism is now well established [10-14], and removing antibiotics from feed (as proposed by recent FDA guidance for industry) has previously been shown to induce various changes within the chicken GI microbiome [15-18].”
BackgroundClostridium difficile – From Colonization to Infection
Schäffler, H., & Breitrück, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00646 · Cited by 174
“…composition can also be investigated in murine models, allowing the examination of factors which lead to the resistance of C. difficile colonization and subsequent development of CDI (Chen et al., 2008; Reeves et al., 2011, 2012; Buffie et al., 2012; Lawley et al., 2012; Winston et al., 2016).”
BackgroundHirsch, B. E., Saraiya, N., Poeth, K., Schwartz, R. M., Epstein, M. E., & Honig, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0930-z · Cited by 165
“It is thought that a sufficiently complex bolus of bacteria reverses the suppressive effect of the pathogen on the endogenous microbiome, allowing the re-establishment of colonization resistance [73].”
BackgroundWinston, J. A., & Theriot, C. M. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.003 · Cited by 218
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Kociolek, L. K., & Gerding, D. N. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.220 · Cited by 166
Seekatz, A. M., Theriot, C. M., Molloy, C. T., Wozniak, K. L., Bergin, I. L., & Young, V. B. (2015) · Infection and Immunity · doi:10.1128/iai.00459-15 · Cited by 142
“Our results in a murine model of CDI relapse corroborate those observed by others in both animal models (33, 35) and humans (14–16), suggesting that additional assistance in restoration of the microbiota may be required to allow complete treatment of CDI without the development of recurrence in patients.”
ResultCostello, S. P., Conlon, M. A., Vuaran, M. S., Roberts-Thomson, I. C., & Andrews, J. M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13366 · Cited by 157
Olle, B. (2013) · Nature Biotechnology · doi:10.1038/nbt.2548 · Cited by 160
Policy: how to regulate faecal transplants
Smith, M. B., Kelly, C., & Alm, E. J. (2014) · Nature · doi:10.1038/506290a · Cited by 140
The intestinal microbiota and susceptibility to infection in immunocompromised patients
Taur, Y., & Pamer, E. G. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283630dd3 · Cited by 144
Passmore, I. J., Letertre, M. P. M., Preston, M. D., Bianconi, I., Harrison, M. A., Nasher, F., Kaur, H., Hong, H. A., Baines, S. D., Cutting, S. M., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007191 · Cited by 142
Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice
Grazul, H., Kanda, L. L., & Gondek, D. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1138197 · Cited by 135
Ruiz, V. E., Battaglia, T., Kurtz, Z. D., Bijnens, L., Ou, A., Engstrand, I., Zheng, X., Iizumi, T., Mullins, B. J., Müller, C. L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00531-6 · Cited by 142
Horve, P. F., Lloyd, S., Mhuireach, G. Á., Dietz, L. G., Fretz, M., MacCrone, G., Wymelenberg, K. G. V. D., & Ishaq, S. L. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-019-0157-y · Cited by 144
Metadata
- Authors
- Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., Deakin, L. J., Pickard, D. J., Duncan, S. H., Flint, H. J., Clark, T. G., Parkhill, J., & Dougan, G.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of Aberdeen (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Lawley, Trevor D.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-25
- Volume
- 8
- Issue
- 10
- Pages
- e1002995
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3486913
- OpenAlex
- W2171605634
- Cited by
- 540
- References
- 73
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 19 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 21 · 2019: 37 · 2018: 47 · 2017: 42 · 2016: 71 · 2015: 65 · 2014: 73 · 2013: 61 · 2012: 6
- FWCI
- 45.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust (076964, 098051)
- Medical Research Council (098051, 93614)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile infection, gut microbiota, dysbiosis, bacterial therapy, fecal microbiota transplantation, transmissibility, opportunistic pathogens, microbial metabolites, mouse model
- MeSH terms
- Animals, Enterocolitis, Pseudomembranous, Feces, Female, Intestines, Mice, Inbred C3H, Mice, Inbred C57BL, Molecular Sequence Data, Recurrence, Vancomycin, Clostridioides difficile, Probiotics, Drug Resistance, Bacterial, Mice, Microbial Interactions, Microbial Consortia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.